This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ironwood Pharmaceuticals Inc (IRWD)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 74.30M 75.49M 136.70M 87.28M
Receivables 25.84M 3.21M 1.49M 652.00K
Inventories 4.95M 22.14M 6.70M 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 289.73M 229.13M 184.44M 167.57M
Property, Plant & Equipment, Gross 82.80M 79.06M 74.52M 59.38M
Accumulated Depreciation & Depletion 52.98M 41.69M 36.98M 25.76M
Property, Plant & Equipment, Net 29.83M 37.38M 37.54M 33.62M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 13.96M 12.46M 7.93M 7.78M
Total Non-Current Assets 43.78M 49.83M 45.47M 41.41M
Liabilities & Shareholder Equity
Total Assets 333.51M 278.96M 229.91M 208.98M
Accounts Payable 9.76M 10.19M 21.73M 6.44M
Short Term Debt 1.15M 1.14M 261.00K 233.00K
Other Current Liabilities 4.99M 2.79M 0.00 4.04M
Total Current Liabilities 60.54M 41.04M 54.94M 65.13M
Long Term Debt 162.34M 174.67M 0.00 0.00
Deferred Income Taxes 10.52M 8.82M 11.59M 12.44M
Other Non-Current Liabilities 8.99M 13.07M 19.02M 21.13M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 184.42M 199.70M 30.92M 33.99M
Total Liabilities 244.96M 240.74M 85.86M 99.12M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 88.55M 38.22M 144.05M 109.86M
Common Par 141.00K 121.00K 108.00K 101.00K
Additional Paid In Capital 1.06B 815.93M 648.96M 542.14M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -967.45M -777.83M -505.02M -432.39M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -19.00K 2.00K 5.00K 6.00K
Total Capitalization 250.89M 212.90M 144.05M 109.86M
Total Equity 88.55M 38.22M 144.05M 109.86M
Total Liabilities & Stock Equity 333.51M 278.96M 229.91M 208.98M
Total Common Shares Outstanding 140.82M 121.17M 107.77M 100.72M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 136.81M 115.85M 106.40M 99.87M
Diluted Weighted Shares Outstanding 136.81M 115.85M 106.40M 99.87M
Number of Employees 464 534 530 276
Number of Part-Time Employees 0 0 0 0
IRWD News

IRWD Ironwood Pharmaceuticals Inc

Analysts Ratings for IRWD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 1
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET IRWD ANALYST REPORT

Brokerage Partners

IRWD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs